Advertisement

Urinary Bladder

  • American Joint Committee on Cancer

Summary of Changes

The definition of TNM and the Stage Grouping for this chapter have not changed from the Fifth Edition.

Keywords

Bladder Cancer Radical Cystectomy Invasive Bladder Cancer Superficial Bladder Cancer Ureteral Orifice 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. Barentsz JO, Jager GJ, Witjes JA, Ruijs JH: Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT. Eur Radiol 6(2):129–133, 1996PubMedCrossRefGoogle Scholar
  2. Brown JL, Russell PJ, Philips J, Wotherspoon J, Raghavan, D: Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Br J Cancer 61:369–376, 1990PubMedCrossRefGoogle Scholar
  3. Cote RJ, Esrig D, Groshen S, et al: p53 and treatment of bladder cancer. Nature 385:123–124, 1997PubMedCrossRefGoogle Scholar
  4. de Vere White RW, Olsson CA, Deitch AD: Flow cytometry: role in monitoring transitional cell carcinoma of bladder. Urology 28:15–20, 1986CrossRefGoogle Scholar
  5. Esrig D, Elmajian D, Groshen S, et al: Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331:1259–1264, 1994PubMedCrossRefGoogle Scholar
  6. Geller NL, Sternberg CN, Penenberg D, Scher H, Yagoda A: Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy. Cancer 67:1525–1531, 1991PubMedCrossRefGoogle Scholar
  7. Greenlee RT, Hill-Harmon MB, Taylor M, Thun M: Cancer Statistics, 2001. CA Cancer J Clin 51:15–36, 2001PubMedCrossRefGoogle Scholar
  8. Herr HW: Staging invasive bladder tumors. J Surg Oncol 51:217–220, 1992PubMedCrossRefGoogle Scholar
  9. Herr HW, Lamm DL, Denis L: Management of superficial bladder cancer. In Raghavan D, Scher HI, Leibel SA, Lange PH (Eds.): Principles and practice of genitourinary oncology. Philadelphia: Lippincott-Raven, 273–280, 1997Google Scholar
  10. Jewett HJ, Strong GH: Infiltrating carcinoma of the bladder: Relation of depth of penetration of the bladder wall to incidence of local extension and metastasis. J Urol 55:366–372, 1946PubMedGoogle Scholar
  11. Johansson SL, Anderstrom CR: Primary adenocarcinoma of the urinary bladder and urachus. In Raghavan D, Brecher MI, Johnson DH, Meropol NJ, Moots PJ, Thigpen JT (Eds.): Textbook of uncommon cancer. Chichester, UK, NY: Wiley-Liss, 29–43, 1999Google Scholar
  12. Koss LG: Tumors of the urinary bladder. In Atlas of tumor pathology, 2nd series, fascicle 11. Washington, DC: Armed Forces Institute of Pathology, 1975.Google Scholar
  13. Loehrer PJ, Einhorn LH, Elson PJ, et al: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 10:1066–1073, 1992PubMedGoogle Scholar
  14. Michaud DS, Spiegelman D, Clinton SK, et al: Fluid intake and the risk of bladder cancer in men. New Engl J Med 340:1390–1397, 1999PubMedCrossRefGoogle Scholar
  15. Neal DE, Marsh C, Bennett MK, et al: Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1:366–368, 1985PubMedCrossRefGoogle Scholar
  16. Pagano F, Bassi P, Ferrante GL, et al: Is stage pT4 (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urology 155:244–247, 1996CrossRefGoogle Scholar
  17. Pagano F, Guazzieri S, Artibani W, et al: Prognosis of bladder cancer. III. The value of radical cystectomy in the management of invasive bladder cancer. Eur Urol 15:166–170, 1988PubMedGoogle Scholar
  18. Raghavan D, Shipley WU, Garnick MB, et al: Biology and management of bladder cancer. N Engl J Med 322:1129–1133, 1990PubMedCrossRefGoogle Scholar
  19. Sarkis AS, Dalbagni G, Cordon-Cardo C, et al: Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J Urol 152:388–392, 1994PubMedGoogle Scholar
  20. Saxman SB, Propert K, Einhorn LH, et al: Long-term follow-up of phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 15:2564–2569, 1997PubMedGoogle Scholar
  21. Shipley WU, Prout GR Jr, Kaufman DS, Peronne TL: Invasive bladder carcinoma: the importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer 60:514, 1987PubMedCrossRefGoogle Scholar
  22. Siemiatycki J, Dewar R, Nadon L, et al: Occupational risk factors for bladder cancer: results from a case-control study in Montreal, Quebec, Canada. Am J Epidemiol 140:1061–1080, 1994PubMedGoogle Scholar
  23. Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M, et al: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784–788, 1994PubMedGoogle Scholar
  24. Stein JP, Ginsberg DA, Grossfeld GD, et al: Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. J Natl Cancer Inst 90:1072–1079, 1998PubMedCrossRefGoogle Scholar
  25. Stein JP, Lieskovsky G, Cote R, et al: Radical cystectomy in the treatment of high grade, invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001, 19(X):66Google Scholar
  26. Sternberg CN, Swanson DA: Non-transitional cell bladder cancer. In Raghavan D, Scher HI, Leibel SA, Lange PH (Eds.): Principles and practice of genitourinary oncology. Philadelphia: Lippincott-Raven, 315–330, 1997Google Scholar
  27. Torti FM, Lum BL, Astron D, et al: Superficial bladder cancer: the primacy of grade in the development of invasive disease. J Clin Oncol 5:125, 1987PubMedGoogle Scholar
  28. Wishnow KI, Levinson AK, Johnson DE: Stage B (P2/3aN0) transitional cell carcinoma of the bladder highly curable by radical cystectomy. Urology 39:12–16, 1992PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • American Joint Committee on Cancer
    • 1
  1. 1.Executive OfficeChicagoUSA

Personalised recommendations